Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
ESMO Open
2024
9
10
Bridging the gap: Leveraging telemedicine and IT infrastructure to connect outpatient oncology practices with specialized expert teams in the management of rare tumors.
Digit Health
2024
10
Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
ESMO Open
2024
9
5
The Technical University of Munich Cancer Center - elevating cancer treatment through science.
Mol Cancer
2024
23
1
Pancreatic Cancer: Current Concepts, Trends, and Future Directions.
Turk J Gastroenterol
2024
36
2
69-81
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.
JHEP Rep
2024
6
10
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Clin Gastroenterol Hepatol
2024
22
5
994-1004.e10
DOTA-Based Plectin-1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue.
Angew Chem Int Ed Engl
2024
63
26
Hourglass, a compass navigating global and regional heterogeneity of pancreatic cancer†.
J Pathol
2024
263
1
5-7